News

AddToAny

Google+ Facebook Twitter Twitter

Tech news: November

This month's top tech news stories

Integra Biosciences

Pipetting robot

Integra Biosciences is giving labs an opportunity to win an Assist Plus pipetting robot. The Assist Plus automates multichannel pipettes and is ideal for a variety of different applications, from PCR to immunoassays.

It is designed to free up time, help streamline daily pipetting tasks and minimise the risk of errors or operator-to-operator variability. For information and to enter the competition, visit the website.

integra-biosciences.com

 


CN Bio

Oncology Service

CN Bio, a leading organ-on-a-chip company that designs and manufactures single- and multi-organ microphysiological systems, has launched its oncology service in response to the global need to improve cancer drug discovery approval rates. The ability of existing approaches to mimic the dynamic drug concentrations in the human body is limited, but the oncology service enables the creation of human and animal PK profiles and applies them to 3D tumour models and organoids.

cn-bio.com


CrestOptics

Microscope module

CrestOptics, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has launched DeepSIM – a super-resolution module designed to enhance the imaging capabilities of confocal microscope systems.

The DeepSIM module can be used with Crest’s X-light V3 spinning disk, or alternative confocal systems, to offer high-resolution images for life science researchers.

crestoptics.com

 

Image credit | Crest Optics |Bio Innovations 2021|Integra-Biosciences

 

Related Articles

A dark winter ahead?

The NHS faces a tough winter. Already under pressure from the backlog of cases that built up during the pandemic, the spectre of a COVID resurgence, along with the usual seasonal flu, threatens to overwhelm services.

Diagnosing children’s cancer in the pandemic

A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic.

Natural killer cells vs. macrophages

New knowledge about naturally acquired malaria immunity may improve vaccines, it is claimed.

A time for reflection

David Wells looks back over his first six months as Chief Executive of the IBMS.

Top